Skip to main content
Premium Trial:

Request an Annual Quote

World Bank Branch to Invest $6.5M in Ocimum Biosolutions; Cash Will Fund CRO

NEW YORK (GenomeWeb News) - Ocimum Biosolutions, an Indian bioinformatics company offering microarray services and contract research services, today said a private branch of the World Bank will invest $6.5 million of equity in the company.
 
Iyad Malas, International Finance Corporation Director for South Asia, said the funds would be used to “establish an internationally competitive contract research outsourcing company and promote the discovery of new drugs.” He said it would also help the company institute better governance standards.
 
Ocimum said its US operations will continue to focus on bio-molecular contract research services and its Indian operations will continue to offer bioinformatics services.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.